UnratedDrug recall · FDA · Published March 26, 2019
GE Healthcare Thallous Chloride TI 201 Injection Recall: Chemical Contamination Risk
GE Healthcare recalls Thallous Chloride TI 201 Injection due to trace impurities detected in the product. This medication is for medical use only and requires immediate attention from healthcare providers.
“GE Healthcare Thallous Chloride TI 201 Injection Recall: Chemical Contamination Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39068-ge-healthcare-thallous-chloride-ti-201-injection-recall-chemical-contamination. Based on FDA recall #D-1134-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1134-2019%22&limit=1).
The FDA announced on March 26, 2019, that Medi-Physics Inc. dba GE Healthcare recalled Thallous Chloride TI 201 Injection due to chemical contamination from an impurity in the manufacturing reagent.
How to tell if you have it
Brand: GE Healthcare
Product: Thallous Chloride TI 201 Injection
Specific Concentration: 37 MBq/mL (1 mCi/mL)
Total Activity: 325.6 MBq (8.8 mCi)
Volume: 8.8 mL vial
NDC: 17156-299-18
Lot: 2090-190841
Expiration: 3/30/3019
The hazard
Trace amounts of an impurity were detected in the reagent used to manufacture the finished product, resulting in chemical contamination.
Context
GovInfoNow's records show GE Healthcare issued recalls for Omnipaque 300 mg/mL Injection and Omnipaque Injection on March 24, 2026, both citing particulate matter hazards. B. Braun Medical recalled 100mL Sodium Chloride Injection on August 19, 2026, for a similar particulate matter hazard.
How to tell if you have this one
Look for the product name 'Thallous Chloride TI 201 Injection' with specific concentration 37 MBq/mL (1 mCi/mL) and total activity 325.6 MBq (8.8 mCi). The vial size is 8.8 mL, and it is labeled as Rx Only. The NDC code is 17156-299-18 and lot number 2090-190841.
Brand
GE Healthcare
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the product name, concentration, and NDC code to confirm if it matches the recalled items.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1134-2019 (March 26, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1134-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.